MedTrace Logo

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

NCT01901107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1078

Last updated 2017-01-27

No results posted yet for this study

Summary

The purpose of this survey is to evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

Conditions

  • Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis

Interventions

DRUG

Kiklin capsules

oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01901107 on ClinicalTrials.gov